Stem cell‐based treatments for Type 1 diabetes mellitus: bone marrow, embryonic, hepatic, pancreatic and induced pluripotent stem cells
Authors:
- 7 December 2011
- journal article
- review article
- Published by Wiley in Diabetic Medicine
- Vol. 29 (1) , 14-23
Abstract
Diabet. Med. 29, 14–23 (2012) Type 1 diabetes mellitus—characterized by the permanent destruction of insulin‐secreting β‐cells—is responsive to cell‐based treatments that replace lost β‐cell populations. The current gold standard of pancreas transplantation provides only temporary independence from exogenous insulin and is fraught with complications, including increased mortality. Stem cells offer a number of theoretical advantages over current therapies. Our review will focus on the development of treatments involving tissue stem cells from bone marrow, liver and pancreatic cells, as well as the potential use of embryonic and induced pluripotent stem cells for Type 1 diabetes therapy. While the body of research involving stem cells is at once promising and inconsistent, bone marrow‐derived mesenchymal stem cell transplantation seems to offer the most compelling evidence of efficacy. These cells have been demonstrated to increase endogenous insulin production, while partially mitigating the autoimmune destruction of newly formed β‐cells. However, recently successful experiments involving induced pluripotent stem cells could quickly move them into the foreground of therapeutic research. We address the limitations encountered by present research and look toward the future of stem cell treatments for Type 1 diabetes.Keywords
This publication has 51 references indexed in Scilit:
- Pancreas vs. islet transplantation: a call on the futureCurrent Opinion in Organ Transplantation, 2010
- Metabolic Long-Term Follow-Up of Functioning Simultaneous Pancreas-Kidney Transplantation Versus Pancreas Transplantation Alone: Insights and LimitationsTransplantation, 2010
- Pancreas transplantationThe Lancet, 2009
- Successful Islet Transplantation From the Pancreata of Non–Heart-Beating DonorsTransplantation Proceedings, 2008
- The Pig as the Donor of Pancreatic Islets for MenVeterinary Research Communications, 2007
- Islet Transplantation as a Treatment for Diabetes — A Work in ProgressNew England Journal of Medicine, 2004
- Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID miceNature, 2000
- Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive RegimenNew England Journal of Medicine, 2000
- Embryonic Stem Cell Lines Derived from Human BlastocystsScience, 1998
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993